Clinical Trials in Tennessee

Showing 16781-16800 of 20,239 trials

Dose Ranging Study

NCT01802723

Dose Ranging Study

Periumbilical Subcutaneous Adipose Tissue Reduction

Neothetics, Inc472 participantsStarted Feb 2013

Beverly Hills, California, United States • Encinitas, California, United States • Los Angeles, California, United States +19 more locations

COMPLETED29 miles

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

NCT00229658

This is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace. Health care providers and subjects selected for study participation are intended to be representative of those providers prescribing, and subjects receiving, SYMLIN therapy.

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

AstraZeneca1,297 participantsStarted Sep 2005

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tucson, Arizona, United States +104 more locations

Dose Ranging Study

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Find Trials by Condition in Tennessee

Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

The BRILLIANT Study

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Assessmet of Patients With PAH Right Ventricular Volume

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme